Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110388396 | 11038839 | 6 | F | 201503 | 20160714 | 20150416 | 20160726 | EXP | US-PFIZER INC-2015125875 | PFIZER | 68.00 | YR | F | Y | 42.18000 | KG | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110388396 | 11038839 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY (SINCE ABOUT 3 YEARS AGO) | A410702 | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||
| 110388396 | 11038839 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY | A527301 | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||
| 110388396 | 11038839 | 3 | SS | ELIQUIS | APIXABAN | 1 | 2.5 MG, 2X/DAY | Y | 0 | 2.5 | MG | FILM-COATED TABLET | BID | ||||||
| 110388396 | 11038839 | 4 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
| 110388396 | 11038839 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 100 UG, 1X/DAY | 0 | 100 | UG | QD | ||||||||
| 110388396 | 11038839 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 100 UG, 1X/DAY (QD) | 0 | 100 | UG | QD | ||||||||
| 110388396 | 11038839 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 1 UG, 1X/DAY | 0 | 1 | UG | QD | |||||||
| 110388396 | 11038839 | 8 | C | ALBUTEROL. | ALBUTEROL | 1 | Oral | 4 MG, AS NEEDED (4 TIMES A DAY, AS NEEDED) | 0 | 4 | MG | TABLET | |||||||
| 110388396 | 11038839 | 9 | C | ALBUTEROL. | ALBUTEROL | 1 | Oral | 1 DF, 4X/DAY (QID) | 0 | 1 | DF | TABLET | QID | ||||||
| 110388396 | 11038839 | 10 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | TABLET | |||||||||||
| 110388396 | 11038839 | 11 | C | TORSEMIDE. | TORSEMIDE | 1 | 20 MG ^1X PER DAY/2X DAY ALTERNATING DOSE | 0 | 20 | MG | TABLET | ||||||||
| 110388396 | 11038839 | 12 | C | TORSEMIDE. | TORSEMIDE | 1 | Unknown | 1 DF, 1X/DAY | 0 | 1 | DF | TABLET | QD | ||||||
| 110388396 | 11038839 | 13 | C | TORSEMIDE. | TORSEMIDE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | TABLET | |||||||
| 110388396 | 11038839 | 14 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 110388396 | 11038839 | 15 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Unknown | 50 UG, 1X/DAY (2 SPRAYS ONCE A DAY) | 0 | 50 | UG | QD | |||||||
| 110388396 | 11038839 | 16 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Unknown | 50 UG, 1X/DAY | 0 | 50 | UG | QD | |||||||
| 110388396 | 11038839 | 17 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | UNK (2 SPRAY) | 0 | |||||||||||
| 110388396 | 11038839 | 18 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 INHALATION TWICE A DAY | 0 | 1 | DF | INHALATION GAS | BID | ||||||
| 110388396 | 11038839 | 19 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK, 1X/DAY | 0 | INHALATION GAS | QD | |||||||||
| 110388396 | 11038839 | 20 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 1 DF, 2X/DAY | 0 | 1 | DF | INHALATION GAS | BID | ||||||
| 110388396 | 11038839 | 21 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 DF, 1X/DAY | 0 | 1 | DF | INHALATION GAS | QD | |||||||
| 110388396 | 11038839 | 22 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK UNK, AS NEEDED (90MCG/SOLUTION) | 0 | |||||||||||
| 110388396 | 11038839 | 23 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 110388396 | 11038839 | 24 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 110388396 | 11038839 | 25 | C | CALTRATE 600+D | 2 | UNK, 1X/DAY | 0 | QD | |||||||||||
| 110388396 | 11038839 | 26 | C | ALBUMIN | ALBUMIN HUMAN | 1 | 5 %, 4X/DAY | 0 | 5 | PCT | EYE DROPS | QID | |||||||
| 110388396 | 11038839 | 27 | C | ALBUMIN | ALBUMIN HUMAN | 1 | Ophthalmic | 5 %, 3X/DAY | 0 | 5 | PCT | EYE DROPS | TID | ||||||
| 110388396 | 11038839 | 28 | C | POTASSIUM | POTASSIUM | 1 | UNK, ALTERNATE DAY | 0 | QOD | ||||||||||
| 110388396 | 11038839 | 29 | C | POTASSIUM | POTASSIUM | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
| 110388396 | 11038839 | 30 | C | VITRON-C | 2 | UNK, 1X/DAY | 0 | QD | |||||||||||
| 110388396 | 11038839 | 31 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | UNK | 0 | |||||||||||
| 110388396 | 11038839 | 32 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 400, 1X/DAY | 0 | QD | ||||||||||
| 110388396 | 11038839 | 33 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, 1X/DAY (QD) | 0 | 40 | MG | QD | |||||||
| 110388396 | 11038839 | 34 | C | HYDROCODONE | HYDROCODONE | 1 | Unknown | 1 DF, 3X/DAY Q8H | 0 | 1 | DF | TID | |||||||
| 110388396 | 11038839 | 35 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 1 DF, 3X/DAY (TID) | 0 | 1 | DF | TID | |||||||
| 110388396 | 11038839 | 36 | C | ALBUTEROL HFA | ALBUTEROL SULFATE | 1 | UNK PRN | 0 | |||||||||||
| 110388396 | 11038839 | 37 | C | ALBUTEROL HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 110388396 | 11038839 | 38 | C | CALTRATE | CALCIUM CARBONATE | 1 | 1 DF, 1X/DAY | 0 | 1 | DF | QD | ||||||||
| 110388396 | 11038839 | 39 | C | VITIRON | 2 | UNK, 1X/DAY | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110388396 | 11038839 | 1 | Pulmonary hypertension |
| 110388396 | 11038839 | 4 | Pulmonary hypertension |
| 110388396 | 11038839 | 5 | Thyroid disorder |
| 110388396 | 11038839 | 6 | Thyroid disorder |
| 110388396 | 11038839 | 8 | Asthma |
| 110388396 | 11038839 | 9 | Pulmonary hypertension |
| 110388396 | 11038839 | 10 | Pulmonary hypertension |
| 110388396 | 11038839 | 11 | Diuretic therapy |
| 110388396 | 11038839 | 12 | Pulmonary hypertension |
| 110388396 | 11038839 | 13 | Cardiac disorder |
| 110388396 | 11038839 | 14 | Anxiety |
| 110388396 | 11038839 | 15 | Seasonal allergy |
| 110388396 | 11038839 | 18 | Pulmonary hypertension |
| 110388396 | 11038839 | 22 | Dyspnoea |
| 110388396 | 11038839 | 23 | Asthma |
| 110388396 | 11038839 | 26 | Dry eye |
| 110388396 | 11038839 | 30 | Blood iron |
| 110388396 | 11038839 | 33 | Anxiety |
| 110388396 | 11038839 | 34 | Nervous system disorder |
| 110388396 | 11038839 | 35 | Nervous system disorder |
| 110388396 | 11038839 | 36 | Dyspnoea |
| 110388396 | 11038839 | 37 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110388396 | 11038839 | OT |
| 110388396 | 11038839 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110388396 | 11038839 | Back pain | |
| 110388396 | 11038839 | Bone disorder | |
| 110388396 | 11038839 | Heart rate increased | |
| 110388396 | 11038839 | Hypotension | |
| 110388396 | 11038839 | Nerve compression | |
| 110388396 | 11038839 | Paraesthesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110388396 | 11038839 | 3 | 201503 | 20160117 | 0 | |
| 110388396 | 11038839 | 4 | 20130625 | 0 | ||
| 110388396 | 11038839 | 32 | 2013 | 0 | ||
| 110388396 | 11038839 | 34 | 201503 | 0 | ||
| 110388396 | 11038839 | 35 | 201503 | 0 |